. Tfh cells are defined by expression of the transcription factor Bcl6, chemokine receptor CXCR5, and surface receptors PD-1 and ICOS. Differentiation of Tfh cells requires T cell interaction with dendritic cells and B cells and signaling by ICOS and cytokines (Crotty, 2014) . Although the GC response is usually induced by foreign antigen stimulation in peripheral lymphoid organs, it is continuously present in Peyer's patches (PPs) and contributes to the production of secretive immunoglobulin A (IgA) for gut immune homeostasis. This spontaneous GC formation is maintained by perpetual exposure to gut microbiota and strictly depends upon Tfh cell help (Fagarasan et al., 2010) . GC formation and Tfh cell development in PPs are abrogated in ICOS-deficient mice (Gigoux et al., 2009; Iiyama et al., 2003) , illustrating the essential role of ICOS in both peripheral and mucosal Tfh cell differentiation. However, signaling mechanisms underlying Tfh cell differentiation, particularly in PPs, remain essentially unexplored.
T cell differentiation is accompanied by dynamic metabolic reprogramming (MacIver et al., 2013) . One of the crucial regulators of anabolic metabolism is mechanistic target of rapamycin (mTOR) signaling, which is composed of two distinct kinase complexes, mTOR complex 1 (mTORC1) and 2 (mTORC2) that are characterized by the signature components Raptor and Rictor, respectively (Chi, 2012) . Recent studies have revealed discrete functions of mTORC1 and mTORC2 in effector CD4 + T cell differentiation (Chi, 2012) . The metabolic function of mTOR signaling in T cells has been mainly ascribed to mTORC1 (Finlay et al., 2012; Yang et al., 2013; Zeng et al., 2013) , while mTORC2 negatively controls anabolic metabolism in CD8 + T cells (Pollizzi et al., 2015) . A recent study shows that shRNAmediated silencing of mTOR or Raptor, but not Rictor, in activated T cells enhances Tfh cell differentiation (Ray et al., 2015) , indicating an inhibitory role of mTORC1 and metabolism in Tfh cell differentiation. However, this conclusion appears to be contrary to the positive roles of PI3K signaling in Tfh cell responses (Gigoux et al., 2009; Rolf et al., 2010) . Furthermore, Bcl6 has been shown to directly inhibit glycolytic genes in T helper 1 (Th1) and CD8 + T cells (Oestreich et al., 2014 ). Yet, Bcl6 hi Tfh cells show higher proliferation and increased expression of cell-cycle-related genes compared to Bcl6 lo Tfh cells (Kitano et al., 2011) , and Tfh cells also exhibit a higher rate of proliferation than other effector T cells (Lü thje et al., 2012) . Finally, expression of the glucose transporter Glut1 and increased glycolysis have been shown to promote effector T cell function and proliferation (Jacobs et al., 2008; Macintyre et al., 2014) . Detailed metabolic requirements and the interplay with signaling events in Tfh cells, however, remain to be established.
Here we tested the role of mTORC1 and mTORC2 and glucose metabolism in Tfh cell differentiation and the ability to promote GC responses. We found that both mTORC1 and mTORC2 were crucial positive determinants of Tfh and GC responses by orchestrating discrete transcriptional programs. mTORC1 and mTORC2 were activated by ICOS to promote metabolism including glycolysis and lipogenesis, while mTORC1 also directly contributed to ICOS expression. Importantly, direct manipulation of metabolic activities through the transcription factor Myc or Glut1 modulated Tfh cell responses. Our study demonstrates that mTORC1 and mTORC2 play non-redundant roles in Tfh cell differentiation by linking immune signals to anabolic metabolism and transcriptional activity.
RESULTS mTOR Signaling Is Sufficient and Necessary for GC and Tfh Responses in PPs
To investigate how mTOR signaling shapes GC and Tfh cell responses under steady state, we examined PPs from Cd4 cre Pten fl/fl mice with T cell-specific deletion of PTEN, a crucial negative regulator of PI3K and mTOR signaling (Chi, 2012) . PPs from wild-type (WT) mice contained a sizable population of B cells expressing GC markers GL-7 and Fas, and of T cells expressing Tfh cell markers PD-1 and CXCR5 (Figures 1A and 1B) . PTEN deficiency significantly increased the frequencies of GC B cells and Tfh cells in PPs (Figures 1A and 1B) . Because PTEN also possesses functions independent of PI3K-Akt (Shen et al., 2007; Song et al., 2011) , we used Cd4-Cre to ectopically express a constitutively active form of the PI3K catalytic subunit p110a (encoded by Pik3ca) (Srinivasan et al., 2009) in T cells (referred to as Pik3ca*). GC B cell and Tfh cell frequencies were markedly enhanced in Cd4 cre Pik3ca* mice (Figures S1A and S1B). Next, to test the requirement of mTOR, we treated WT mice with rapamycin, an immunosuppressant that targets mTORC1 primarily but also mTORC2 under long-term treatment (Chi, 2012) . Rapamycin strongly reduced GC B and Tfh cells in PPs ( Figure 1C) . Therefore, over-activation of PI3K-mTOR and inhibition of mTOR exert positive and negative effects on GC B and Tfh cells in PPs, respectively. Although PI3K-Akt is a classical activator of mTOR (Chi, 2012) , PI3K-Akt-independent pathways of mTOR activation have been identified (Deane et al., 2007; Donahue and Fruman, 2007; Finlay et al., 2012 T cells ( Figure S1C ). In PPs, Rictor deficiency resulted in a more pronounced reduction of MP T cells than Raptor deficiency ( Figure S1D ), suggesting a preferential role for mTORC2 in PPs. Indeed, we observed a reduced frequency and number Figure 1D and Figure S1E (Fagarasan et al., 2010 1H ). Thus, mTORC2 plays a prominent role in IgA production in PPs.
T follicular regulatory T cells (Tfr) constrain Tfh cell differentiation (Chung et al., 2011; Linterman et al., 2011) , and so the diminished Tfh cells in PPs in Raptor or Rictor-deficient mice could be due to elevated Tfr cell function. However, Raptor deficiency in Treg cells abrogates their suppressive function Figure S1F ). Also, Treg-specific deletion of Rictor via Foxp3-Cre had little effect on Tfh and GC B cells in PPs ( Figure S1G ). The blunted Tfh cell differentiation in Raptor or Rictor-deficient mice is thus unlikely to arise from Tfr cell functional enhancement.
mTOR in Activated T Cells Is Critical for Tfh Cell Differentiation and GC Formation in PPs Because mTORC1 is required for early T cell activation , compromised T cell activation in the Cd4-Cre-mediated gene deletion could complicate data interpretation. We therefore used a deleter line with Cre expression mediated by the OX40 promoter to induce deletion in CD4 + T cells after initial activation (Kang et al., 2013) . As expected, Raptor and Rictor mRNA were not completely depleted in CD4 + T cells until 3 days after in vitro activation ( Figure 2A) . Also, CD4 + T cells from OX40
cre Rptor fl/fl and OX40 cre Rictor fl/fl mice had largely normal proliferation within the first 2 days of stimulation ( Figure 2B ). MP T cells are known to express OX40 (Klinger et al., 2009 Figure 2C ). Flow cytometry analysis verified markedly reduced GC B and Tfh cells in PPs from these mice ( Figures 2D and 2E ). In contrast, T cell proliferation and apoptosis (data not shown) and generation of Th1, Th2, and Th17 cells ( Figure S2C ) were largely unaffected. Figure 2G and Figure S2D ). This defect was not evident in spleen or mesenteric lymph nodes ( Figure 2G ), suggesting a possible defect in T cell distribution. Indeed, examination of 
Rptor
fl/fl mice were diminished as well, albeit to a lesser degree ( Figure 2I ). Of note, we found a modest reduction of Tfr cells in OX40 cre Rictor fl/fl mice ( Figure S2E) ; however, because Treg-specific deletion of Rictor did not affect Tfh or GC cells in PPs ( Figure S1G ), Tfr cells seemed unlikely to cause defective Tfh cell differentiation. These data demonstrate that mTORC1 and mTORC2 promote spontaneous Tfh cell differentiation, GC formation, and IgA production in PPs in a cell-intrinsic manner and mTORC2 promotes proper T cell localization within PPs. Figure 3A ). These molecules are known to be under the control of Foxo1 (Kerdiles et al., 2009; Ouyang et al., 2009) . Considering the requirement of Rictor in CD4 + T cell abundance in PPs selectively ( Figure 2G ), we asked whether T cells from different lymphoid tissues exhibit differential expression of Foxo1-dependent targets. MP CD4 + T cells from PPs showed highest expression of CD69, but lowest expression of CD127, CCR7, and CD62L ( Figure 3B ), as well as S1pr1 and Klf2, also targets of Foxo1 ( Figure 3C ). Thus, MP T cells from PPs have reduced Foxo1-dependent gene expression compared to those from peripheral lymphoid organs. Foxo1 is a key negative regulator for Tfh cell differentiation (Stone et al., 2015; Xiao et al., 2014 Figure 3G ). More probes, however, showed altered expression in only one of the mutant cells, with 1,093 probes in Raptor-deficient (R4) and 455 probes in Rictor-deficient cells (R2) ( Figure 3G ). A heatmap of differentially expressed genes showed that Raptor and Rictor control both overlapping and distinct gene-expression profiles ( Figure S3C ). We performed gene-set enrichment analysis (GSEA) to compare gene expression of Raptor or Rictor-deficient T cells versus WT cells. This unbiased approach identified a number of downregulated pathways in both Raptor and Rictor-deficient T cells, including cell cycle, pyruvate metabolism and citric acid TCA cycle, glucose metabolism, and lipid metabolism (Figure S3D ). In contrast, cholesterol biosynthesis was suppressed in Raptor-deficient cells selectively, while cytokine-cytokine receptor interaction and chemokine-chemokine receptor pathways were upregulated in the absence of Rictor, but not Raptor ( Figure S3D ). When applying GSEA to curate the transcriptional signatures of Tfh cells (Choi et al., 2015; Yusuf et al., 2010) , we found inhibition of Tfh cell gene signatures in Raptor and Rictor-deficient cells ( Figure 3H ). There was little overlap between Raptor and Rictor-dependent Tfh cell signatures, suggesting that mTORC1 and mTORC2 mediate discrete programs of Tfh cell differentiation ( Figure 3H ). This was further supported by ingenuity pathway analysis (IPA) that revealed activation of immune cell trafficking in the absence of Rictor but not Raptor ( Figure S3E ). Thus mTORC1 and mTORC2 orchestrate both overlapping and distinct gene-expression programs in cell metabolism, immune functions, and Tfh cell differentiation. Figure S4E ), while Rictor deficiency slightly elevated Th1 cells ( Figure S4F ). Therefore, both mTORC1 and mTORC2 are required for Tfh and GC B cell responses upon viral infection, whereas mTORC1 but not mTORC2 contributes to Th1 cell differentiation.
mTORC1 and mTORC2 Promote Foreign AntigenInduced Tfh Cell Responses
To further assess the role of mTORC1 and mTORC2 in GC responses, we immunized mice with ovalbumin linked to 4-hydroxy-3-nitrophenylacetyl hapten (NP-OVA) (Shrestha et al., 2015) . Both OX40 cre Rptor fl/fl and OX40 cre Rictor fl/fl mice had reduced GC B cells in the spleen (Figures 5A and 5B) and draining lymph nodes (data not shown). Confocal microscopic analysis revealed smaller size of GCs ( Figure 5C ), and analysis of serum antibodies showed reduction of anti-NP IgM and IgG, and IgG subtypes IgG1, IgG2c, and IgG3 titers ( Figure 5D ). OX40
cre Rptor fl/fl and OX40 cre Rictor fl/fl mice also had markedly reduced Tfh cells, as revealed by co-expressed markers PD-1 and CXCR5 ( Figures 5E and 5F ), ICOS and CXCR5 (Figure S5A ), or Bcl6 and CXCR5 ( Figure S5B ). Altogether, mTORC1 and mTORC2 are required for Tfh cell differentiation, GC formation, and humoral responses after foreign antigen immunization.
To test whether the requirements of mTORC1 and mTORC2 in Tfh cell differentiation are cell-autonomous, we immunized mixed BM chimeras (as described in Figures 4G and 4H) Figure 5I ). Collectively, mTORC1 and mTORC2 are required for Tfh cell differentiation after immunization via T cell-intrinsic and antigen-specific mechanisms.
Raptor or Rictor Deficiency Impairs ICOS-Induced Signaling and Metabolism
We determined upstream and downstream pathways mediated by mTORC1 and mTORC2 for Tfh cell differentiation. Expression of Tfh cell-associated transcription factors Bcl6 and IRF4 (Bollig et al., 2012 ) was undisturbed by Raptor or Rictor deficiency (Figure 6A) . ICOS, which regulates late-stage Tfh cell differentiation via Foxo1 (Stone et al., 2015; Weber et al., 2015) , was modestly reduced in the absence of Raptor, but not Rictor, in the spleen after immunization or PPs under steady state ( Figure 6B ). Because mTORC2 mediates ICOS-induced Foxo1 nuclear exclusion ( Figure 3D ), we examined expression of Foxo1-dependent target genes in splenic Tfh cells after NP-OVA immunization. Rictor-deficient Tfh cells expressed higher amounts of Foxo1 target genes, including Klf2, Il7r, and Ccr7 ( Figure 6C ). Flow cytometry analysis revealed increased expression of CD62L and CD127 and reduced expression of CD69 ( Figure 6D ). Altogether, loss of Raptor modestly reduces ICOS expression, whereas Rictor deficiency upregulates Foxo1 gene targets. To examine ICOS-induced signaling events, we stimulated T cell blasts from OX40 6G ) and glycolysis ( Figure 6H ), but such enhancement was blunted by deficiency of Raptor or Rictor ( Figures 6F-6H ). Moreover, defective glucose uptake was evident in vivo in Tfh cells from immunized cre Rictor fl/fl mice, as indicated by staining with the glucose analog, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) ( Figure 6I ). Finally, we transferred naive OT-II T cells to recipient mice, and NP-OVA immunization activated all donor T cells by day 5, as indicated by the uniformly high CD44 expression ( Figure S6A ). We compared Tfh cells to non-Tfh cells ( Figure S6B ) in terms of cell size, 2-NBDG staining, CD71 and CD98 expression ( Figure S6C ), and expression of key glycolytic genes ( Figure S6D ). In all cases, Tfh cells exhibited higher metabolic activities. Therefore, mTORC1 and mTORC2 link ICOS stimulation to metabolic activities.
The proto-oncogene Myc mediates metabolic reprogramming of T cells responding to antigen stimulation . To test whether Myc was important for Tfh cell differentiation, we generated OX40
cre Myc fl/fl mice. OX40 cre Myc fl/fl mice showed a profound reduction of GC and Tfh cells following antigen stimulation ( Figure 6J ), as well as in PPs under steady state (Figure 6K) . Thus, Myc function is required for Tfh cell differentiation.
Glucose Metabolism Regulates Tfh Cell Differentiation
We next directly tested the metabolic requirements of Tfh cells.
To this end, we differentiated naive CD4 T cells in vitro to generate Tfh-like cells (Awe et al., 2015) , which expressed IL-21, Bcl6, CXCR5, PD-1, and ICOS ( Figures S7A-S7C ). Metabolite profiles were generated using high-resolution mass spectrometry to compare the metabolome of Tfh-like cells with that of activated T cells (Tact) and Th1 and Th17 cells. Each subset was metabolically distinct (Figures 7A and 7B ). Pathway analyses of altered metabolites showed that amino acid, amino sugar metabolism, and glycolytic intermediates trended higher in Tfh-like cells, but Tfh-like cells had lower amount of TCA metabolites and intermediates in cysteine and glycerophospholipid metabolism (Table S1 ). Consistent with Tfh cell reliance on both glucose and mitochondrial metabolism pathways, treatment of in vitro differentiated Tfh-like cells with low doses of either glycolysis inhibitor 2-deoxyglucose (2-DG) or electron transport inhibitor rotenone led to reduced number of IL-21-producing CD4 + T cells ( Figure 7C ). Our data show that mTOR signaling promotes glucose metabolism and uptake in Tfh cells in vivo. Indeed, in vitro induced Tfh-like cells expressed elevated Glut1 (Figures 7D and 7E ). Likewise, Glut1 expression was higher on Tfh cells relatively to other non-Tfh CD4 + T cells from PPs ( Figure 7F ) and spleens (Figure S7D ). Glut1 expression was partly dependent on mTORC1 signaling, as rapamycin treatment reduced Glut1 expression in vitro ( Figure S7E and S7F). Consistent with this finding, Glut1 expression was reduced in Raptor-deficient, but not Rictor-deficient, Tfh cells after LCMV infection ( Figure S7G ). Rapamycin treatment also suppressed glucose uptake ( Figure S7H ) of in vitro Tfh-like cells. T cells with transgenic expression of Glut1 (Slc2a1-Tg), however, were able to maintain elevated glucose uptake even when treated with rapamycin ( Figure S7H ). Shortterm treatment with rapamycin did not affect IL-21 expression in Slc2a1-Tg T cells, while it suppressed IL-21 expression in WT T cells ( Figure 7G ). Long-term treatment of rapamycin reduced IL-21 expression in both WT and Slc2a1-Tg T cells, but the latter still showed increased resistance to rapamycin ( Figure S7I ).
The role of glucose uptake in Tfh cell differentiation was next tested by directly modulating Glut1 expression. While no difference in Tfh cell responses was observed in mice with T cell-specific deletion of Glut1 (Cd4 cre Slc2a1 fl/fl ) after immunization with sheep red blood cells (SRBC) (Figure S7J ), this genetic modification did not alter glucose uptake in Tfh cells ( Figure S7K ) and instead led to compensatory upregulation of Glut3 ( Figure S7L ). Thus, we tested whether increased glucose uptake in Slc2a1-Tg mice altered Tfh cell differentiation. Relative to non-transgenic controls, GC B cells and IgA-expressing B cells were elevated in PPs from Slc2a1-Tg mice under steady state ( Figures 7H  and 7I) . Examination of Tfh cell signature proteins, CXCR5, PD-1, ICOS, and Bcl6, revealed increased Tfh cells in the PPs of Slc2a1-Tg mice ( Figure 7J and Figures S7M and S7N) . Further, we immunized WT mice with KLH and analyzed Glut1 expression on Tfh cells in the draining lymph nodes. Similar to steady state, Tfh cells expressed higher Glut1 relatively to activated non-Tfh CD4 + cells ( Figure S7O ). Moreover, Tfh cells were significantly enriched in immunized Slc2a1-Tg mice ( Figure 7K ). Thus, Glut1 promotes the generation of Tfh cells under steady state and upon foreign antigen challenge.
DISCUSSION
Despite the recent identification of specific receptors and transcription factors underlying Tfh cell differentiation (Crotty, 2014) , the intracellular processes linking these events remain poorly understood. Here we identified mTORC1 and mTORC2 signaling as a key mechanism that links ICOS to anabolic metabolism and transcriptional regulation, thereby driving Tfh cell differentiation and humoral immunity. mTORC1 and mTORC2 orchestrate distinct transcriptional programs, with mTORC2 selectively affecting Foxo1 activity. Moreover, ICOS stimulation strongly upregulated glycolysis and lipid biosynthesis, and loss of either mTORC1 or mTORC2 diminished such metabolic activities. These data, together with the results from Glut1-transgenic and Myc-deficient systems that demonstrated the effects of in vivo metabolic modulation on Tfh cell responses, support the crucial roles of glucose metabolism in Tfh cell differentiation. Altogether, our study illustrates that mTORC1 and mTORC2 link immune signals to metabolic and transcriptional activities for Tfh cell differentiation. Spontaneous Tfh cell generation maintains GC responses in PPs that contribute to mucosal IgA production (Fagarasan et al., 2010) , but the underlying molecular pathways remain elusive. Our study links mTOR and cellular metabolism to Tfh cell differentiation in PPs. Whereas both mTORC1 and mTORC2 are important in this process, mTORC2 is selectively required for proper T cell localization in PPs, expression of Foxo1 targets, and nuclear exclusion of Foxo1 upon ICOS ligation. Reduced Tfh cell differentiation in Rictor-deficient mice could be partially restored by deletion of one allele of Foxo1, highlighting an ICOS-mTORC2-Foxo1 signaling axis in Tfh cell responses. Of note, whereas previous work in CD8 + T cells associates mTORC1 with T cell migration (Finlay and Cantrell, 2011; Finlay et al., 2012) , our results here reveal a function of mTORC2 in mediating CD4 + T cell accumulation specifically in PPs. Also, in contrast to other effector T cell subsets in which mTORC1 generally plays a dominant role relative to mTORC2 (Chi, 2012) , mTORC2 plays a more prominent role in Tfh cell differentiation and immune homeostasis in PPs. These findings highlight the unique signaling requirements of Tfh cells.
A recent report has found that shRNA-mediated silencing of mTOR or Raptor enhances Tfh cell frequency following (G and H) (legend continued on next page) (Ray et al., 2015) , suggesting that Tfh and Th1 cells could have different sensitivity to reduced mTOR activity. We also note that our results using PTEN-deficient or PI3K over-activation mice are consistent with previous studies that show a positive role of PI3K signaling in Tfh cell differentiation (Gigoux et al., 2009; Rolf et al., 2010) . Recent studies highlight distinct metabolic requirements for different T cell states and fates (MacIver et al., 2013) . Our studies show that while Tfh cells utilize and require oxidative metabolism, glucose uptake and glycolysis are also important and can promote Tfh cell differentiation in vivo. Bcl6, the master regulator for Tfh cells, has been shown to inhibit glycolysis in vitro (Oestreich et al., 2014) . Compared to Th1 cells, Tfh cells exhibit lower rates of glycolysis and oxidative phosphorylation (Ray et al., 2015) . Conversely, Bcl6 expression and Tfh cells are associated with elevated cell proliferation (Kitano et al., 2011; Lü thje et al., 2012) , demonstrating a use of anabolic metabolism. We show here that Tfh cell differentiation required the interplay between immune signaling from ICOS-mTOR or Tfh cell-promoting cytokines and metabolic reprogramming. This is reminiscent of the role of IL-2-mTORC1-mediated metabolism in orchestrating Treg cell proliferation and suppressive activity ). Our conclusion is further supported by results from inhibition of Myc or increased Glut1 expression, which directly illustrate the crucial role of anabolic metabolism in Tfh cell differentiation. Tfh cells might utilize this mixed metabolism to support both proliferation and cellular longevity while not depleting nutrients in GCs.
In summary, our study has identified the crucial roles of mTORC1 and mTORC2 in linking ICOS signals to metabolic and transcriptional regulation as a key mechanism for Tfh cell differentiation under various contexts. Tfh cells play an important role in humoral immunity but also contribute to autoimmune diseases. Our results suggest that clinical manipulation of Tfh cells could be accomplished by targeting mTOR signaling or metabolic pathways for therapeutic intervention of immune-mediated diseases.
EXPERIMENTAL PROCEDURES Animals
All mice were kept in specific pathogen-free condition in Animal Resource Center at St. Jude Children's Research Hospital and Duke University. All animal protocols were approved by appropriate Institutional Animal Care and Use Committees. Further information is included in the Supplemental Experimental Procedures.
Tfh-like Cell Culture
Tfh-like cells were generated as described (Awe et al., 2015) . Naive CD4 + T cells were isolated by magnetic beads and cultured on anti-CD3 (10 mg/ml) and anti-CD28 (10 mg/ml)-coated plates in RPMI-1640 media supplemented with 10% FBS, sodium pyruvate, penicillin/streptomycin, HEPES, and b-mercaptoethanol for 3.5 days. The following cytokines were added to generate Tfh-like subset: 100 ng/ml IL-6 (eBioscience), 50 ng/ml IL-21 (R&D Systems), 10 mg/ml of each anti-IL-2, anti-IFN-g (eBioscience), anti-IL-4 (eBioscience, clone 11B11), and anti-TGF-b (eBioscience) (Awe et al., 2015) (Awe et al., 2015) . In some experiments, cells were treated with 5 nM rotenone, 250 mM 2-DG, rapamycin (50 nM), or DMSO vehicle.
Flow Cytometry
For analysis of surface markers, cells were stained in PBS containing 2% (wt/ vol) fetal bovine serum (FBS). Flow cytometry data were acquired on LSRII or LSR Fortessa (BD Biosciences) or MACSQuant (Miltenyi) and analyzed using Flowjo software (Tree Star). Further information is included in the Supplemental Experimental Procedures.
Immunofluorescence
Fresh frozen PPs were cryosectioned, stained with antibodies, and imaged using Nikon TiE inverted microscope and an EMCCD camera (Andor). To analyze Foxo1 intracellular localization, we fixed, permeabilized, and stained cells with antibodies, imaged using a Marianis spinning disk confocal microscope (Intelligent Imaging Innovations) and EMCCD camera, and analyzed using Slidebook software (Intelligent Imaging Innovations). Details are included in the Supplemental Experimental Procedures.
Fecal IgA Measurement
Fecal pellets were collected, weighed, and resuspended in PBS with complete protease inhibitor (Roche) at 100 mg/ml. The tubes were taped horizontally on a vortex and shake vigorously for 10 min. The suspensions were centrifuged at 400 g for 5 min to pellet large debris. Supernatants were filtered through a 70 mM cell strainer, and the flow-through was collected and centrifuged at 8,000 g for 5 min. Supernatants were collected and IgA concentration was measured by ELISA (eBioscience).
ICOS Stimulation
After 3 days activation, live T cells were purified using Ficoll. Cells were rested for 3 hr and then incubated with anti-ICOS (5 mg/ml; C398.4A; Biolegend) followed by crosslinking with goat anti-hamster antibody (Jackson ImmunoResearch).
Metabolic Flux Analysis
Glycolytic flux was determined by measuring the detritiation of [3-3 H] glucose . De novo lipogenesis was measured as described before . Details are included in the Supplemental Experimental Procedures.
Metabolomics
Metabolomic analyses were performed using LC Q Exactive Mass Spectrometer (LC-QE-MS) (Thermo Scientific) . MetaboAnalyst was used to analyze range-scale data and provide PCA and KEGG pathway analysis of metabolites significantly changed (1.5-fold difference, p < 0.05) (www. metaboanalyst.ca/).
Gene-Expression Profiling
Details are included in the Supplemental Experimental Procedures.
Statistical
Analysis p values were calculated with unpaired Student's t test, Mann-Whitney test, or analysis of variance (GraphPad Prism) as specified in figure legends, with proper post-test analysis performed.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO) database under the accession number GSE85555. 
